Assessment of pharmacokinetic drug-drug interaction between pradigastat and acetaminophen in healthy subjects

被引:0
|
作者
Surya Ayalasomayajula
Dan Meyers
Phillip Koo
Atish Salunke
Tapan Majumdar
Sam Rebello
Gangadhar Sunkara
Jin Chen
机构
[1] Novartis Institutes for BioMedical Research,
[2] Novartis Institutes for BioMedical Research,undefined
[3] Novartis Healthcare Pvt. Ltd,undefined
关键词
Pharmacokinetics; Drug-drug interaction; Pradigastat; Acetaminophen; Gastric motility;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:425 / 432
页数:7
相关论文
共 50 条
  • [31] A PHARMACOKINETIC STUDY TO EVALUATE DRUG-DRUG INTERACTIONS BETWEEN PREGABALIN AND TRAMADOL IN HEALTHY SUBJECTS.
    Lee, S.
    Kim, Y.
    Hwang, I.
    Im, G. -J.
    Lee, S.
    Chung, J. -Y.
    Yoon, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S41 - S42
  • [32] Mirtazapine and paroxetine: a drug-drug interaction study in healthy subjects
    Ruwe, FJL
    Smulders, RA
    Kleijn, HJ
    Hartmans, HLA
    Sitsen, JMA
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2001, 16 (06) : 449 - 459
  • [33] Pharmacokinetic Drug-Drug Interaction Study of Omecamtiv Mecarbil With Omeprazole, a Proton Pump Inhibitor, in Healthy Subjects
    Trivedi, Ashit
    Sohn, Winnie
    Jafarinasabian, Pegah
    Zhang, Hanze
    Terminello, Bianca
    Flach, Stephen
    Abbasi, Siddique
    Dutta, Sandeep
    Lee, Edward
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (01): : 129 - 133
  • [34] Absence of pharmarokinctic drug-drug interaction between telbivudine and lamivudine or adefavir in healthy subjects
    Zhou, XJ
    Lloyd, D
    Constance, BF
    Chao, G
    Brown, NA
    GASTROENTEROLOGY, 2005, 128 (04) : A745 - A746
  • [35] Evaluation of Drug-Drug Interaction Potential between Baloxavir Marboxil and Oseltamivir in Healthy Subjects
    Kawaguchi, Nao
    Koshimichi, Hiroki
    Ishibashi, Toru
    Wajima, Toshihiro
    CLINICAL DRUG INVESTIGATION, 2018, 38 (11) : 1053 - 1060
  • [36] A pharmacokinetic drug-drug interaction study between selexipag and midazolam, a CYP3A4 substrate, in healthy male subjects
    Juif, Pierre-Eric
    Boehler, Margaux
    Donazzolo, Yves
    Bruderer, Shirin
    Dingemanse, Jasper
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (09) : 1121 - 1128
  • [37] Evaluation of pharmacokinetic drug- drug interaction between tegoprazan and clarithromycin in healthy subjects
    Oh, Minkyung
    Lee, Heechan
    Kim, Seokuee
    Kim, Bongtae
    Song, Geun Seog
    Shin, Jae-Gook
    Ghim, Jong-Lyul
    TRANSLATIONAL AND CLINICAL PHARMACOLOGY, 2023, 31 (02) : 114 - 123
  • [38] Pharmacokinetic drug-drug interaction analysis of pyramax® and ritonavir in healthy volunteers
    Duparc, S.
    Borghini-Fuhrer, I.
    Fleckenstein, L.
    Jung, D.
    Lopez-Lazaro, L.
    Methaneethorn, J.
    Morris, C.
    Pokorny, R.
    Shin, C. -S.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2011, 16 : 138 - 138
  • [39] ASSESSMENT OF PHARMACOKINETIC DRUG-DRUG INTERACTION BETWEEN LCZ696 AND AMLODIPINE.
    Hsiao, H.
    Greeley, M.
    Pal, P.
    Langenickel, T.
    Rajman, I.
    Sunkara, G.
    Chandra, P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S45 - S46
  • [40] Pharmacokinetic Drug-Drug Interaction Study Between Raltegravir and Atorvastatin 20 mg in Healthy Volunteers
    Blonk, Maren
    van Beek, Michiel
    Colbers, Angela
    Schouwenberg, Bas
    Burger, David
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 69 (01) : 44 - 51